NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 37 min ago

Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy

Fri, 2023-03-31 10:09
Notice NOT-OD-23-106 from the NIH Guide for Grants and Contracts

Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)

Fri, 2023-03-31 04:34
Funding Opportunity RFA-MH-23-300 from the NIH Guide for Grants and Contracts. This initiative aims to address the gaps in our knowledge about the data, barriers, facilitators, and strategies to advance universal mental health coverage in LMICs. As NIMH continues to support the development, adaptation, and testing of interventions across the globe, it is vital to expand the knowledge-based to inform the adoption and scaling of these evidence-based interventions. This FoA supports innovative experimental and non-experimental research to improve the understanding of critical supply- and demand-side elements needed to augment the access and utilization of mental health services in these settings.

BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional)

Fri, 2023-03-31 04:17
Funding Opportunity RFA-MH-23-130 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for creating the Data Coordination and Artificial Intelligence Center (DCAIC) for the Brain Behavior Quantification and Synchronization (BBQS) Consortium of the BRAIN Initiative. The FOA will support a single award to a multi-disciplinary team with a single or multiple PIs working on the five interrelated areas:1) Data Management; 2) Data Standards; 3) ML/AI Resources; 4) Data Ecosystem; and 5) Dissemination, Training and Coordination.

BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)

Fri, 2023-03-31 04:10
Funding Opportunity RFA-MH-23-110 from the NIH Guide for Grants and Contracts. The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Thu, 2023-03-30 13:45
Funding Opportunity PAR-23-148 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

Notice of Special Interest (NOSI): Administrative Supplement for Collaborative Projects Supported by the NIAID RNCP and CCRP

Thu, 2023-03-30 13:38
Notice NOT-AI-23-037 from the NIH Guide for Grants and Contracts

Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)

Thu, 2023-03-30 04:17
Funding Opportunity RFA-CA-23-023 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to establish collaborations between liver cancer investigators and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Liver Cirrhosis Network (LCN) members to advance our understanding of hepatocellular carcinoma (HCC) as the result of liver cirrhosis and its etiologic risks, development, progression, early diagnosis, and treatment. The funds available through this FOA will support new multidisciplinary liver cancer-specific collaborations between eligible liver cancer investigators and one or more of the NIDDK-funded LCN members. This structure is intended to maximize the effectiveness of the network by facilitating collaborative opportunities that enhance the scientific goals of the collaborating units and the LCN as a whole. Applicants selected for NCI funding will become members of the Liver Cirrhosis Network-Liver Cancer Collaboratory (LCN-LCa) Committee.

Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)

Thu, 2023-03-30 03:52
Funding Opportunity RFA-OD-23-015 from the NIH Guide for Grants and Contracts. As part of the ADVANCE: Advancing Prevention Research for Health Equity program, the NIH Office of Disease Prevention (ODP) within the Office of the Director Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) is soliciting revision applications (formerly called "competitive revisions") to active R01 grants to support studies that develop and evaluate menthol cigarette smoking cessation and prevention interventions for populations that experience health disparities.

Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)

Thu, 2023-03-30 03:40
Funding Opportunity PAR-23-152 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Thu, 2023-03-30 03:40
Funding Opportunity PAR-23-153 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Tue, 2023-03-28 13:23
Funding Opportunity PAR-23-132 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Tue, 2023-03-28 13:23
Funding Opportunity PAR-23-133 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed)

Tue, 2023-03-28 13:11
Funding Opportunity RFA-AI-23-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research focused on the development of convenient small animal models that will support infection and replication of HBV and/or HCV, ideally leading to the dichotomous outcomes of clearance and persistence. Alternatively, closely related surrogate virus-host systems or robust xenotransplantation models dually engrafted with human liver cells and human immune systems can be developed.

NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)

Tue, 2023-03-28 13:01
Funding Opportunity RFA-RM-23-007 from the NIH Guide for Grants and Contracts. The NIH Director's Early Independence Award supports rigorous and promising junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)

Tue, 2023-03-28 12:55
Funding Opportunity RFA-MH-23-260 from the NIH Guide for Grants and Contracts. This NIMH RFA concept seeks applications proposing experimental and non-experimental research that evaluates multilevel preventive strategies to reduce suicide risk (suicide ideation and behavior, including acts of self-harm/suicide) and promote resilience across the life span in low-and middle-income countries (LMICs). Globally, there is a critical need to implement culturally adapted multilevel preventive approaches at the individual (selective prevention) and population level (universal prevention) for people across the lifespan in LMICs, focusing on multiple risks and protective factors.

Pages